Mesenchymal stem cells in perianal Crohn's disease

Tech Coloproctol. 2020 Aug;24(8):883-889. doi: 10.1007/s10151-020-02250-5. Epub 2020 Jun 1.

Abstract

The use of mesenchymal stem cells has resulted in a breakthrough for the treatment of complex perianal fistulas in Crohn's disease. This novel treatment is associated with a minimally invasive surgical technique that can be well defined. However, our previous experience has taught us that neglecting any of the critical steps in the operation can result in frequent treatment failure. We have put together a comprehensive guide, a stepwise algorithm, for our minimally invasive approach to identify common pitfalls and reduce treatment failures. Using data we have collected over the past 15 years from drug development, execution of clinical trials, and enacting an advanced educational training program, we spelt out each stage of the minimally invasive surgical intervention for stem cell delivery for perianal Crohn's disease. In this article, we provide 21 tips for a correct approach during the five major phases of the surgical procedure. To optimize the efficacy of mesenchymal stem cells for perianal Crohn's disease, a standardized minimally invasive technique including a reliable and reproducible series of key steps should be utilized.

Keywords: Crohn’s disease; Mesenchymal stem cells; Minimally invasive surgery; Perianal fistula; Surgical protocol.

MeSH terms

  • Crohn Disease* / therapy
  • Cutaneous Fistula*
  • Humans
  • Mesenchymal Stem Cell Transplantation*
  • Mesenchymal Stem Cells*
  • Rectal Fistula* / etiology
  • Rectal Fistula* / surgery
  • Treatment Outcome